Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CaptionCall is a leading provider of captioned telephone services designed for individuals with hearing loss who need visual support to communicate effectively over the phone. The company provides specialized hardware, including the CaptionCall phone, as well as mobile applications that utilize advanced speech-to-text technology and human captioning assistants to provide real-time transcription of conversations. As a certified provider under the Americans with Disabilities Act (ADA), CaptionCall's services are funded through the FCC's Telecommunications Relay Service (TRS) fund, making them available at no cost to eligible users in the United States. The company focuses on improving the quality of life for the hard-of-hearing community by facilitating social connection and independence. CaptionCall is a subsidiary of Sorenson, a global leader in communication tools for the deaf and hard-of-hearing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CaptionCall.